✦ LIBER ✦

Inhibition of the PI3K/AKT pathway potentiates cytotoxicity of EGFR kinase inhibitors in triple-negative breast cancer cells

✍ Scribed by Yi, Yong Weon; Hong, Wooyoung; Kang, Hyo Jin; Kim, Hee Jeong; Zhao, Wenjing; Wang, Antai; Seong, Yeon-Sun; Bae, Insoo

Book ID: 120230713
Publisher: Carol Davila University of Medicine Bucharest, Romania
Year: 2013
Tongue: English
Weight: 412 KB
Volume: 17
Category: Article
ISSN: 1582-1838
DOI: 10.1111/jcmm.12046

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The PI3K/AKT/MTOR Signaling Pathway: The

The PI3K/AKT/MTOR Signaling Pathway: The Role of PI3K and AKT Inhibitors in Breast Cancer

✍ Huemer, Florian; Bartsch, Rupert; Gnant, Michael 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 355 KB

Reduced PTEN expression in breast cancer

Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway

✍ deGraffenried, L. A. 📂 Article 📅 2004 🏛 Oxford University Press 🌐 English ⚖ 195 KB

90 POSTER Differential effects of blocka

90 POSTER Differential effects of blockade of the HER3-PI3K-Akt pathway by EGFR kinase inhibitors and EGFR monoclonal antibodies on combinations with IGF-1R kinase inhibition

✍ E. Buck; A. Eyzaguirre; D. Epstein; J. Pachter; J. Haley; N. Miglarese; K. Iwata 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Inhibitors of the PI3-kinase/Akt pathway

Inhibitors of the PI3-kinase/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells

✍ Therese H Hemström; Margareta Sandström; Boris Zhivotovsky 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 696 KB

## Abstract Non‐small cell lung cancer cells (NSCLC) are more resistant to anticancer treatment as compared with other types of cancer cells. Recently (Hemström __et al__., Exp Cell Res 2005;305:200–13) we showed that apoptosis of U1810 NSCLC cells induced by the staurosporine analog PKC 412 correl

A novel multi-kinase inhibitor pazopanib

A novel multi-kinase inhibitor pazopanib suppresses growth of synovial sarcoma cells through inhibition of the PI3K-AKT pathway

✍ Seiichi Hosaka; Keisuke Horiuchi; Masaki Yoda; Robert Nakayama; Takahide Tohmond 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 473 KB

559 POSTER The role of the ErbB3/PI3K/AK

559 POSTER The role of the ErbB3/PI3K/AKT pathway in determining breast cancer cell sensitivity against the irreversible dual EGFR/ErbB2 inhibitor EKB-569

✍ W. Shabbir; C. Brünner-Kubarth; M. Grusch; W. Berger; B. Marian; R. Wagner; D. L 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 56 KB